Literature DB >> 14718839

Duplex ultrasound scan findings two years after great saphenous vein radiofrequency endovenous obliteration.

Olivier Pichot1, Lowell S Kabnick, Denis Creton, Robert F Merchant, Sanja Schuller-Petroviae, James G Chandler.   

Abstract

OBJECTIVE: To assess the clinical and duplex ultrasound scan findings in the groin and thigh 2 years after great saphenous vein (GSV) radiofrequency endovenous obliteration (RFO).
METHODS: Sixty-three limbs in 56 patients with symptomatic varicose veins and GSV incompetence were treated with RFO, usually with adjunctive stab-avulsion phlebectomies, and examined at a median follow-up of 25 months, by using a color-coded, duplex sonography protocol that mandated views in at least two planes of the saphenofemoral junction (SFJ) and its tributaries and at three GSV levels in the thigh.
RESULTS: The commonest duplex finding in the groin was an open, competent, SFJ with a < or =5-cm patent terminal GSV segment conducting prograde tributary flow through the SFJ (82%). Despite the presence of a total of 104 patent junctional tributaries, SFJ reflux was uncommon, affecting only five limbs. GSV truncal occlusion was observed in 90% of treated GSVs. Limited segmental treatment was successful in three limbs with a midthigh reflux source well below competent terminal and subterminal valves. Six GSV trunks had partial or no occlusion, but only one refluxed. These were anatomical RFO failures (9.5%) but were clinically improved, including the refluxing limb. Neovascularity was not identified in any groin. Thigh varicosities were observed in 12 limbs, including telangiectasias and isolated small tributary branches. New varicosities, linked to refluxing thigh perforators (two), or patent SFJ tributaries (three), were present in five limbs.
CONCLUSION: RFO is the ideological opposite of high ligation without GSV stripping. It leaves physiologic tributary flow relatively undisturbed, does not incite groin neovascularity, eliminates the GSV as a refluxing conduit in >90% of limbs and has a 2-year, postadjunctive phlebectomy varicosity prevalence of 7.9%, with symptom score improvement in 95% of limbs with an initial score higher than zero.

Entities:  

Mesh:

Year:  2004        PMID: 14718839     DOI: 10.1016/j.jvs.2003.07.015

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

Review 1.  [Diagnosis and treatment of varicose veins: part 2: therapeutic procedures and results].

Authors:  H Nüllen; T Noppeney
Journal:  Chirurg       Date:  2010-12       Impact factor: 0.955

2.  The endovenous ASVAL method: principles and preliminary results.

Authors:  Mehmet Mahir Atasoy; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 3.  Significance of Reflux Abolition at the Saphenofemoral Junction in Connection with Stripping and Ablative Methods.

Authors:  Cestmir Recek
Journal:  Int J Angiol       Date:  2015-03-23

Review 4.  [Current status of standard and endovascular varicosity surgery].

Authors:  T Noppeney; H Nüllen
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

Review 5.  The treatment of varicose veins.

Authors:  S Subramonia; T A Lees
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

6.  Imaging of venous insufficiency.

Authors:  Neil M Khilnani; Robert J Min
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

7.  Comparison of endovenous laser treatment and high ligation in treatment of limb varicosity: A meta-analysis.

Authors:  Gang Cao; Han-Cheng Gu; Ji-Ting Wang; Qiang Huang; Jian-Chun Cao
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

8.  Current treatment of varicose veins.

Authors:  François Becker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

9.  Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-02-01

Review 10.  [Primary varicosis].

Authors:  T Noppeney; S Rewerk; M Winkler; H Nüllen; H C Schmedt
Journal:  Chirurg       Date:  2007-07       Impact factor: 0.920

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.